Unintended target effect of anti-BCL-2 DNAi
Abdul Shukkur Ebrahim,1 Mustapha Kandouz,2 Nada Emara,1 Amara B Sugalski,3 Leonard Lipovich,3 Ayad M Al-Katib1 1Lymphoma Research Laboratory, 2Department of Pathology, School of Medicine, 3Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA Introduction: Previous res...
Main Authors: | Ebrahim AS, Kandouz M, Emara N, Sugalski AB, Lipovich L, Al-Katib AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/unintended-target-effect-of-anti-bcl-2-dnai-peer-reviewed-article-CMAR |
Similar Items
-
Targeted Downregulation of MYC through G-quadruplex Stabilization by DNAi
by: Alexandra Maria Psaras, et al.
Published: (2021-09-01) -
DNAi-peptide nanohybrid smart particles target BCL-2 oncogene and induce apoptosis in breast cancer cells
by: Mohsen Alipour, et al.
Published: (2023-10-01) -
Shorter Cilia Length and Aberrant Ciliated Marker DNAI1 in Allergic Rhinitis
by: Zhou S, et al.
Published: (2023-01-01) -
The Effect of Synthesis of Pegylated Nanoliposome Containing DNAi on Reduction of BCL-2 Gene Expression in DLCL2 Cell Line
by: Farahnaz Boozari Saravani, et al.
Published: (2018-12-01) -
Identification of a novel founder variant in DNAI2 cause primary ciliary dyskinesia in five consanguineous families derived from a single tribe descendant of Arabian Peninsula
by: Dalal A. Al-Mutairi, et al.
Published: (2022-10-01)